Healthcare Value Capital’s Rigel Pharmaceuticals RIGL Stock Holding History

Healthcare Value Capital’s Portfolio RIGL Stock Details RIGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-15,000	Closed	-$536K	–	35
2015 Q1	$536K	Sell	15,000 -25,000	-63%	-$685K	0.58%	28
2014 Q4	$908K	Hold	40,000	–	–	1.66%	14
2014 Q3	$776K	Buy	40,000 +30,000	+300%	+$847K	0.75%	20
2014 Q2	$363K	Sell	10,000 -5,000	-33%	-$170K	0.3%	30
2014 Q1	$582K	Sell	15,000 -5,000	-25%	-$178K	0.38%	34
2013 Q4	$570K	Buy	+20,000	New	+$587K	0.42%	30

Other funds holding RIGL

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Healthcare Value Capital's RIGL Position: Q2 2015 in Review

Healthcare Value Capital sold out of Rigel Pharmaceuticals (RIGL) in Q2 2015, closing a stake of 15,000 shares — an estimated $536K sold.

Healthcare Value Capital first reported a position in RIGL in Q4 2013 and held it in 6 quarters. The position peaked at $908K in Q4 2014. 123 funds tracked by Wall St. Rank hold RIGL as of Q2 2015.

Healthcare Value Capital reported no remaining Rigel Pharmaceuticals position as of Q2 2015 after selling out during the quarter.
Healthcare Value Capital sold 15,000 Rigel Pharmaceuticals shares in Q2 2015, an estimated $536K.
Healthcare Value Capital first reported a position in Rigel Pharmaceuticals in Q4 2013 and held it in 6 quarters.
Healthcare Value Capital's Rigel Pharmaceuticals position peaked at $908K in Q4 2014.
123 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q2 2015.

Based on Healthcare Value Capital's 13F filing for Q2 2015, filed 14 Aug 2015.